Vertex Pharmaceuticals Incorporated
Clinical trials sponsored by Vertex Pharmaceuticals Incorporated, explained in plain language.
-
New narcolepsy drug VX-433 enters first human safety tests
Symptom relief Not yet recruitingThis early-stage study tests VX-433, an experimental drug for people with narcolepsy type 1, to see if it is safe and how the body handles it. About 118 adults will receive single or multiple doses, and researchers will also check how VX-433 affects other drugs like midazolam and…
Phase: PHASE1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated May 26, 2026 05:51 UTC
-
Healthy volunteers needed to test pain drug interaction
Knowledge-focused Not yet recruitingThis early-stage study looks at how a drug called efavirenz changes the way a new pain medicine (suzetrigine) moves through the body. It involves 18 healthy adults and does not aim to treat any condition. The main goal is to measure drug levels and check for side effects when bot…
Phase: PHASE1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated May 26, 2026 05:48 UTC